140 related articles for article (PubMed ID: 7962523)
1. CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.
Ganju RK; Sunday M; Tsarwhas DG; Card A; Shipp MA
J Clin Invest; 1994 Nov; 94(5):1784-91. PubMed ID: 7962523
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-mediated regulation of CD10/neutral endopeptidase transcripts in acute lymphoblastic leukemias.
Ishimaru F; Potter NS; Shipp MA
Exp Hematol; 1996 Jan; 24(1):43-8. PubMed ID: 8536791
[TBL] [Abstract][Full Text] [Related]
4. CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation.
Sunday ME; Hua J; Torday JS; Reyes B; Shipp MA
J Clin Invest; 1992 Dec; 90(6):2517-25. PubMed ID: 1469102
[TBL] [Abstract][Full Text] [Related]
5. Loss of CD10/NEP Expression in the Pulmonary Carcinogenesis.
Myoug N
Cancer Res Treat; 2002 Feb; 34(1):17-22. PubMed ID: 26680837
[TBL] [Abstract][Full Text] [Related]
6. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
Bunn PA; Helfrich BA; Brenner DG; Chan DC; Dykes DJ; Cohen AJ; Miller YE
Clin Cancer Res; 1998 Nov; 4(11):2849-58. PubMed ID: 9829752
[TBL] [Abstract][Full Text] [Related]
8. CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung.
Shipp MA; Tarr GE; Chen CY; Switzer SN; Hersh LB; Stein H; Sunday ME; Reinherz EL
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10662-6. PubMed ID: 1660144
[TBL] [Abstract][Full Text] [Related]
9. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
Strassheim D; Shafer SH; Phelps SH; Williams CL
Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
[TBL] [Abstract][Full Text] [Related]
10. CD10/neutral endopeptidase 24.11 regulates fetal lung growth and maturation in utero by potentiating endogenous bombesin-like peptides.
King KA; Hua J; Torday JS; Drazen JM; Graham SA; Shipp MA; Sunday ME
J Clin Invest; 1993 May; 91(5):1969-73. PubMed ID: 8486767
[TBL] [Abstract][Full Text] [Related]
11. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of neutral endopeptidase expression and enzymatic activity during the differentiation of human choriocarcinoma cells.
Uehara C; Ino K; Suzuki T; Kajiyama H; Kikkawa F; Nagasaka T; Mizutani S
Placenta; 2001 Jul; 22(6):540-9. PubMed ID: 11440542
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated down-regulation of neutral endopeptidase (NEP; EC 3.4.24.11; CD10) on immature B lymphocytes by dexamethasone.
Cupic B; Breljak D; Gabrilovac J
Int J Mol Med; 2005 Jun; 15(6):1023-31. PubMed ID: 15870909
[TBL] [Abstract][Full Text] [Related]
16. CD10/neutral endopeptidase inhibition augments pulmonary neuroendocrine cell hyperplasia in hamsters treated with diethylnitrosamine and hyperoxia.
Willett CG; Shahsafei A; Graham SA; Sunday ME
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):13-20. PubMed ID: 10385588
[TBL] [Abstract][Full Text] [Related]
17. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
[TBL] [Abstract][Full Text] [Related]
18. Murine common acute lymphoblastic leukemia antigen (CD10 neutral endopeptidase 24.11). Molecular characterization, chromosomal localization, and modeling of the active site.
Chen CY; Salles G; Seldin MF; Kister AE; Reinherz EL; Shipp MA
J Immunol; 1992 May; 148(9):2817-25. PubMed ID: 1374101
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
20. Regulation of lung branching morphogenesis by bombesin-like peptides and neutral endopeptidase.
Aguayo SM; Schuyler WE; Murtagh JJ; Roman J
Am J Respir Cell Mol Biol; 1994 Jun; 10(6):635-42. PubMed ID: 8003340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
